• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Understanding Cancer Changes and Testing: How Testing Guides Your Metastatic Breast Cancer Treatment

by MM360 Staff | May 1, 2025 | Uncategorized

Source: CureToday articles Panelists discuss how testing for specific changes in cancer cells, like ESR1 mutations, can help guide treatment choices for patients with hormone receptor-positive metastatic breast cancer. Read More

Recapping Every FDA Approval Announced in April for Cancer Care

by MM360 Staff | May 1, 2025 | Uncategorized

Source: CureToday articles Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types. Read More

Managing Fatigue During Breast Cancer Treatment: Tips for Conserving Energy

by MM360 Staff | May 1, 2025 | Uncategorized

Source: CureToday articles Breast cancer treatment is a physical, emotional, and mental challenge. Facing cancer and its side effects demands extraordinary physical, emotional, and spiritual stamina. Read More

Triage Health Conference: Free Education to Navigate Health Care

by MM360 Staff | May 1, 2025 | Uncategorized

Source: CureToday articles Triage Health offers free, expert-led education on the legal and practical issues that impact individuals coping with chronic or serious medical conditions. Read More

Advances in surgical techniques and targeted therapies for Pancreatic Cancer

by MM360 Staff | May 1, 2025 | Uncategorized

Source: CureToday articles Pancreatic cancer is one of the most challenging cancers to treat. Read More

The Impact of Breast Cancer on Self-Image

by MM360 Staff | May 1, 2025 | Uncategorized

Source: CureToday articles A breast cancer diagnosis brings about many losses. Read More
« Older Entries
Next Entries »

Recent Content

  • Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma
  • Subcutaneous Darzalex Faspro Extends PFS in Smoldering Myeloma
  • A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients
  • Subcutaneous Bortezomib Associated With Reduced Incidence of Peripheral Neuropathy in Multiple Myeloma
  • Multiple Myeloma: Key Insights on Diagnosis and Evolving Treatment Strategies
  • Multiple myeloma associated long non-coding RNA PLUM confers chemoresistance by enhancing PRC2 mediated UPR pathway activation
  • Mobilization of hematopoietic stem cells using G-CSF with or without cyclophosphamide before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma receiving induction therapy with or without daratumumab
  • Incidence and prevalence of clinically detected smoldering multiple myeloma within the general population: a retrospective observational cohort study
  • The long non-coding RNA CRNDE stabilises SIRT1 protein and influences Hedgehog signalling in multiple myeloma
  • What Does Multiple Myeloma Mean?
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT